PTC Therapeutics Inc. (PTCT) had a good day on the market for Friday September 29
shares jumped 14.6% to close at $20.01. About 5.24 million shares traded hands on 29,981 trades for the day, compared with an average daily volume of
841,816 shares out of a total float of 41.39 million. After opening the trading day at $18.32, shares of PTC Therapeutics Inc. stayed within a range of $20.19 to
With today’s gains, PTC Therapeutics Inc. now has a market cap of
$828.19 million. Shares of PTC Therapeutics Inc. have been trading within a range of $22.00
and $4.03 over the last year, and it had a 50-day SMA of $19.61 and a 200-day SMA of $14.80.
PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes.
PTC Therapeutics Inc. is based out of South Plainfield, NJ and has some 298 employees. Its CEO is Stuart W. Peltz.
For a complete fundamental analysis of PTC Therapeutics Inc., check out Equities.com’s Stock Valuation Analysis report for
Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit http://www.equitiespremium.com/ to learn
more about Guild Investment’s Market Commentary and Adam Sarhan’s Find
Leading Stocks today.
PTC Therapeutics Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell
Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an
objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives
a broad, unbiased look at the small-cap market as a whole.
To get more information on PTC Therapeutics Inc. and to follow the company’s latest updates, you can visit the company’s profile page here:
PTCT’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk. Also, don’t forget to sign-up for our daily
email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer